227 related articles for article (PubMed ID: 14640996)
1. Elevated plasma endothelin as an additional cardiovascular risk factor in patients with Cushing's syndrome.
Kirilov G; Tomova A; Dakovska L; Kumanov P; Shinkov A; Alexandrov AS
Eur J Endocrinol; 2003 Dec; 149(6):549-53. PubMed ID: 14640996
[TBL] [Abstract][Full Text] [Related]
2. Subclinical Cushing's syndrome in adrenal incidentaloma.
Terzolo M; Osella G; Alì A; Borretta G; Cesario F; Paccotti P; Angeli A
Clin Endocrinol (Oxf); 1998 Jan; 48(1):89-97. PubMed ID: 9509073
[TBL] [Abstract][Full Text] [Related]
3. Elevated plasma 19-hydroxyandrostenedione levels in Cushing's disease: stimulation with ACTH and inhibition with metyrapone.
Mune T; Morita H; Yasuda K; Murayama M; Yamakita N; Miura K
Clin Endocrinol (Oxf); 1993 Mar; 38(3):265-72. PubMed ID: 8384536
[TBL] [Abstract][Full Text] [Related]
4. Serum levels of dehydroepiandrosterone sulfate in patients with asymptomatic cortisol producing adrenal adenoma: comparison with adrenal Cushing's syndrome and non-functional adrenal tumor.
Morio H; Terano T; Yamamoto K; Tomizuka T; Oeda T; Saito Y; Tamura Y; Sasano H
Endocr J; 1996 Aug; 43(4):387-96. PubMed ID: 8930526
[TBL] [Abstract][Full Text] [Related]
5. Plasma 18-oxocortisol levels in the patients with adrenocortical disorders.
Yamakita N; Mune T; Morita H; Yasuda K; Miura K; Gomez-Sanchez CE
Clin Endocrinol (Oxf); 1994 May; 40(5):583-7. PubMed ID: 8013138
[TBL] [Abstract][Full Text] [Related]
6. How common are polycystic ovaries and the polycystic ovarian syndrome in women with Cushing's syndrome?
Kaltsas GA; Korbonits M; Isidori AM; Webb JA; Trainer PJ; Monson JP; Besser GM; Grossman AB
Clin Endocrinol (Oxf); 2000 Oct; 53(4):493-500. PubMed ID: 11012575
[TBL] [Abstract][Full Text] [Related]
7. Short and long-term responses to metyrapone in the medical management of 91 patients with Cushing's syndrome.
Verhelst JA; Trainer PJ; Howlett TA; Perry L; Rees LH; Grossman AB; Wass JA; Besser GM
Clin Endocrinol (Oxf); 1991 Aug; 35(2):169-78. PubMed ID: 1657460
[TBL] [Abstract][Full Text] [Related]
8. The low-dose dexamethasone suppression test in patients with adrenal incidentalomas: comparisons with clinically euadrenal subjects and patients with Cushing's syndrome.
Tsagarakis S; Kokkoris P; Roboti C; Malagari C; Kaskarelis J; Vlassopoulou V; Alevizaki C; Thalassinos N
Clin Endocrinol (Oxf); 1998 May; 48(5):627-33. PubMed ID: 9666875
[TBL] [Abstract][Full Text] [Related]
9. Plasma testosterone profiles in Cushing's syndrome.
Smals AG; Kloppenborg PW; Benraad TJ
J Clin Endocrinol Metab; 1977 Aug; 45(2):240-5. PubMed ID: 195973
[TBL] [Abstract][Full Text] [Related]
10. Adrenal medulla secretion in Cushing's syndrome.
Mannelli M; Lanzillotti R; Pupilli C; Ianni L; Conti A; Serio M
J Clin Endocrinol Metab; 1994 Jun; 78(6):1331-5. PubMed ID: 8200934
[TBL] [Abstract][Full Text] [Related]
11. Assessment of cortisol and ACTH responses to the desmopressin test in patients with Cushing's syndrome and simple obesity.
Tsagarakis S; Vasiliou V; Kokkoris P; Stavropoulos G; Thalassinos N
Clin Endocrinol (Oxf); 1999 Oct; 51(4):473-7. PubMed ID: 10583315
[TBL] [Abstract][Full Text] [Related]
12. Circadian pattern of serum androgens in women with Cushing's syndrome.
Kreze A; Mikulecky M; Putz Z; Moravcik M
Acta Med Hung; 1992-1993; 49(3-4):171-8. PubMed ID: 1345454
[TBL] [Abstract][Full Text] [Related]
13. Effect of o,p'-DDD on cortisol metabolism in Cushing's syndrome of various etiology.
Koide Y; Inoue S; Murayama H; Kawai K; Yamashita K
Endocrinol Jpn; 1985 Oct; 32(5):615-24. PubMed ID: 3004927
[TBL] [Abstract][Full Text] [Related]
14. Dissociation of adrenal androgen and cortisol secretion in Cushing's syndrome.
Cunningham SK; McKenna TJ
Clin Endocrinol (Oxf); 1994 Dec; 41(6):795-800. PubMed ID: 7889616
[TBL] [Abstract][Full Text] [Related]
15. Adrenal incidentalomas showing unilateral concordant visualization by adrenocortical scintigraphy: comparison with adenomas in Cushing's syndrome.
Tani A; Nakajo M; Tsuchimochi S; Nakabeppu Y; Umanodan T
Ann Nucl Med; 2000 Jun; 14(3):205-12. PubMed ID: 10921486
[TBL] [Abstract][Full Text] [Related]
16. Subclinical Cushing's syndrome in patients with adrenal incidentaloma: clinical and biochemical features.
Rossi R; Tauchmanova L; Luciano A; Di Martino M; Battista C; Del Viscovo L; Nuzzo V; Lombardi G
J Clin Endocrinol Metab; 2000 Apr; 85(4):1440-8. PubMed ID: 10770179
[TBL] [Abstract][Full Text] [Related]
17. Clinical Investigation of Adrenal Incidentalomas in Japanese Patients of the Fukuoka Region with Updated Diagnostic Criteria for Sub-clinical Cushing's Syndrome.
Abe I; Sugimoto K; Miyajima T; Ide T; Minezaki M; Takeshita K; Takahara S; Nakagawa M; Fujimura Y; Kudo T; Miyajima S; Taira H; Ohe K; Ishii T; Yanase T; Kobayashi K
Intern Med; 2018 Sep; 57(17):2467-2472. PubMed ID: 29709936
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular events and mortality in patients with adrenal incidentalomas that are either non-secreting or associated with intermediate phenotype or subclinical Cushing's syndrome: a 15-year retrospective study.
Di Dalmazi G; Vicennati V; Garelli S; Casadio E; Rinaldi E; Giampalma E; Mosconi C; Golfieri R; Paccapelo A; Pagotto U; Pasquali R
Lancet Diabetes Endocrinol; 2014 May; 2(5):396-405. PubMed ID: 24795253
[TBL] [Abstract][Full Text] [Related]
19. Hypothalamic abnormalities in patients with pituitary-dependent Cushing's syndrome.
Stewart PM; Penn R; Gibson R; Holder R; Parton A; Ratcliffe JG; London DR
Clin Endocrinol (Oxf); 1992 May; 36(5):453-8. PubMed ID: 1319858
[TBL] [Abstract][Full Text] [Related]
20. Adrenal incidentaloma: a new cause of the metabolic syndrome?
Terzolo M; Pia A; Alì A; Osella G; Reimondo G; Bovio S; Daffara F; Procopio M; Paccotti P; Borretta G; Angeli A
J Clin Endocrinol Metab; 2002 Mar; 87(3):998-1003. PubMed ID: 11889151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
